Skip to content

A Self-Management Intervention for Youth With Sickle Cell Disease and Their Families: Phase I

Self Management for Families and Youth: Phase I

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03069430
Enrollment
44
Registered
2017-03-03
Start date
2016-08-01
Completion date
2017-03-31
Last updated
2018-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia, Sickle Cell

Brief summary

This study is being conducted to test an intervention for children and adolescents ages 8-17 years with sickle cell disease and their families. In the first phase of this study, key informant interviews are being conducted with health care providers and children ages 8-17 with sickle cell disease and their primary caregivers. Participants are asked to review the intervention and provide feedback that will inform revision to the intervention.

Detailed description

Key informant, semi-structured interviews are conducted using an interview guide to obtain expert provider (healthcare providers of children with SCD) and end-user (children and parents/caregivers) feedback on the intervention. Interview questions are designed to solicit information on advantages and disadvantages, perceived usefulness, and recommendations for improvement on the intervention. The interviews will last approximately 1 hour and are audio recorded. Recordings are transcribed for analysis. Data are analyzed using a deductive-inductive approach with the intervention as a framework for initial categories. Findings will inform revisions to the intervention. Feasibility testing of the revised intervention will be conducted in the next phase of the study.

Interventions

BEHAVIORALSELFY (Self Management for Youth with SCD)

The intervention will be delivered via a mobile device (tablet) and consists of three components. 1. Education, will consist of continuous access to electronic educational resources on the SCD process, treatment, home management strategies, symptom prevention and management strategies. To address potential literacy barriers, an application that reads PDF files aloud will be downloaded onto devices. 2. symptom monitoring and tracking, will consist of an application for tracking and monitoring pain in SCD that also permits upload of symptom logs and text alerts to a health care provider. 3. caregiver-provider communication, consists of SMS messaging with a nurse who will: respond to alerts, monitor pain symptoms delivered via the mHealth application, and respond to text messages.

Sponsors

Medical University of South Carolina
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Children ages 8-17 years and their primary caregiver * Child with SCD as indicated by self/parent report or report from MUSC Pediatric Sickle Cell clinic staff * Child has been seen at the MUSC Pediatric Sickle Cell clinic for at least 6 months * MUSC Pediatric Sickle Cell clinic staff report preventive recommendations are followed by child/caregiver Health care providers: * Age 18 years or older * Healthcare professional with at least 6 months' experience caring for children with SCD

Exclusion criteria

* Non-English speaking * Inability or unwillingness to participate in a one-on-one interview * Inability or unwillingness of parent/caregiver or health care provider to give informed consent and of child to give assent

Design outcomes

Primary

MeasureTime frameDescription
End-user perceptions of intervention using semi-structured, key informant interviewsthrough study completion, approximately one hourThemes or categories developed from analysis of qualitative data on child/caregiver perceptions of the intervention.
Expert provider perceptions of intervention using semi-structured, key informant interviewsthrough study completion, approximately one hourThemes or categories developed from analysis of qualitative data on health care provider perceptions of the intervention.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026